Tamarind Bio

Easy to use computational biology tools for drug discovery

Tamarind Bio is an artificial intelligence company in United States, founded in 2023. It has 1 recorded funding round, most recently a Series A in May 2025.

Employees
1–10
Founded
2023
Business Model
B2B
Last Round
Series AMay 2025
Rounds
1

Indexed holds 1 funding round and 6 investors for this company. to use credits for reveals, or explore the API.

About

Tamarind Bio is a website and API which allows scientists to use computational biology tools at scale using a simple interface. On Tamarind, scientists can use ML models like AlphaFold to design and simulate molecules by simply selecting inputs instead of or setting up a high performance computing environment or dealing with DevOps. Our tools are used by thousands researchers in large pharma companies, top biotechs, and academic institutions. We currently focus on models in protein design and engineering, including for antibodies/therapeutics and enzymes. Get in touch at founders@tamarind.bio

Funding History

Data from Indexed.vcUpdated
Series ASeries AMay 2025

Investors

Tech & App Stack

19 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • AI/ML ×3
  • Cloud/Infrastructure ×3
  • DevOps ×3
  • Data & Prospecting ×2
  • Engineering & DevOps ×2
  • Marketing & SEO ×2
  • +4 more

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tamarind Bio on Indexed.vc
<a href="https://indexed.vc/companies/tamarind-bio"><img src="https://indexed.vc/api/badge/company/tamarind-bio" alt="Tamarind Bio on Indexed.vc" width="260" height="76" /></a>